December 4th 2024
A statistical procedure based on a quality range is proposed for demonstrating comparability between pre-change and post-change process slopes in an accelerated or stressed stability study.
NGS abbreviates drug discovery timelines.
GSK and University of Oxford Partner on Disease Research to Advance Drug Discovery and Development
December 15th 2021GlaxoSmithKline, together with the University of Oxford, has launched the Oxford-GSK Institute under a new collaboration that aims to study complex diseases to accelerate the success of drug discovery and drug development efforts.
Advances in Molecule Characterization and Biomanufacturing for Emerging Therapies: Part 2
November 10th 2021Part 2—Industry experts from MilliporeSigma, Lonza, Astrea Bioseparations, and Sartorius provide insight and examples about solving critical challenges in both analytics and process development for emerging therapies.
SGS Opens New Clinical Research Site in Belgium and Expands Biosafety Testing Capacity in UK
October 28th 2021SGS’s new Antwerp, Belgium, clinical research site will house both clinical trial patients and good manufacturing practice drug manufacturing, and its Glasgow, UK, biosafety testing site now has increased testing capacity.